P. Shrikant

发表

The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.

Qingsheng Li, K. Odunsi, Rajesh R. Rao, 2010, Immunity.

The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation.

P. Shrikant, E. Benveniste, 1996, Journal of immunology.

LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model

K. Odunsi, P. Shrikant, J. Matsuzaki, 2015, Oncotarget.

CD4-Dependent Potentiation of a High Molecular Weight-Melanoma-Associated Antigen-Specific CTL Response Elicited in HLA-A2/Kb Transgenic Mice1

S. Ferrone, P. Shrikant, Xinhui Wang, 2006, The Journal of Immunology.

HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways.

D. Benos, P. Shrikant, E. Benveniste, 1996, Journal of immunology.

Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer

T. Khoury, P. Shrikant, Leighton Stein, 2013, Oncotarget.

B Subunit of Shiga Toxin-Based Vaccines Synergize with α-Galactosylceramide to Break Tolerance against Self Antigen and Elicit Antiviral Immunity1

E. Tartour, W. Fridman, L. Johannes, 2007, The Journal of Immunology.

Alteration of Cell Surface Sialylation Regulates Antigen-Induced Naive CD8+ T Cell Responses1

P. Shrikant, B. Pappu, 2004, The Journal of Immunology.

Rapamycin

P. Shrikant, R. Srivastava, A. Utley, 2012, Oncoimmunology.

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

K. Odunsi, L. Old, P. Shrikant, 2007, Proceedings of the National Academy of Sciences.

IL-12-Programmed Long-Term CD8+ T Cell Responses Require STAT41

Qingsheng Li, K. Odunsi, P. Shrikant, 2006, The Journal of Immunology.

Require STAT 4 T Cell + IL-12-Programmed Long-Term CD 8

Qingsheng Li, K. Odunsi, P. Shrikant, 2006 .

Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses

K. Odunsi, L. Old, P. Shrikant, 2015, Scientific Reports.

Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.

P. Wallace, R. Cheney, K. Odunsi, 2009, Cancer research.

Delivery Gene IL-15 and IL-21 Combined with Expressing the HIV-1 Env Glycoprotein when Immune Responses Induced by DNA Vaccine Increased Level and Longevity of Protective

L. Stamatatos, P. Shrikant, D. Kozbor, 2006 .

Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models

L. Ellis, P. Shrikant, S. Ramakrishnan, 2012, PloS one.

Regulates Antigen-Induced Naive CD 8 Alteration of Cell Surface Sialylation

P. Shrikant, B. Pappu, 2004 .

In Vivo Augmentation of Tumor-Specific CTL Responses by Class I/Peptide Antigen Complexes on Microspheres (Large Multivalent Immunogen)1

P. Shrikant, M. Mescher, J. Goldberg, 2003, The Journal of Immunology.

Multivalent Immunogen ) Complexes on Microspheres ( Large CTL Responses by Class I / Peptide Antigen In Vivo Augmentation of Tumor-Specific

P. Shrikant, M. Mescher, J. Goldberg, 2002 .

Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness.

P. Shrikant, M. Mescher, 1999, Journal of immunology.

CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism.

A. Khoruts, P. Shrikant, M. Mescher, 1999, Immunity.

Differential expression of CCR7 defines two distinct subsets of human memory CD4+CD25+ Tregs.

K. Odunsi, L. Old, D. Valmori, 2008, Clinical immunology.

The acute phase protein haptoglobin regulates host immunity

K. Huntoon, P. Shrikant, F. Berger, 2008, Journal of leukocyte biology.

A unique form of haptoglobin produced by murine hematopoietic cells supports B-cell survival, differentiation and immune response.

L. Garrett-Sinha, Qingsheng Li, K. Huntoon, 2013, Molecular immunology.

Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

K. Odunsi, L. Old, P. Shrikant, 2013, Cancer Immunology Research.

A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity.

Qingsheng Li, K. Odunsi, Kristen N. Pollizzi, 2011, Immunity.

Regulating Mammalian Target of Rapamycin To Tune Vaccination-Induced CD8+ T Cell Responses for Tumor Immunity

Qingsheng Li, W. Gillanders, K. Odunsi, 2012, The Journal of Immunology.

Immunotherapy: Promoting CD8 T Cell Opposing Effects of IL-2 in Tumor

P. Shrikant, M. Mescher, 2002 .

β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10

I. Mellman, Kelvin P Lee, P. Shrikant, 2015, Proceedings of the National Academy of Sciences.

Regulating functional cell fates in CD8 T cells

Qingsheng Li, Rajesh R. Rao, P. Shrikant, 2010, Immunologic research.

Antigen‐induced Erk1/2 activation regulates Ets‐1‐mediated sensitization of CD8+ T cells for IL‐12 responses

Qingsheng Li, K. Odunsi, P. Shrikant, 2010, Journal of leukocyte biology.

Opposing Effects of IL-2 in Tumor Immunotherapy: Promoting CD8 T Cell Growth and Inducing Apoptosis1

P. Shrikant, M. Mescher, 2002, The Journal of Immunology.

Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

C. Morrison, N. Dupont, J. Karbach, 2012, Proceedings of the National Academy of Sciences.

IL-21 Enhances and Sustains CD8+ T Cell Responses to Achieve Durable Tumor Immunity: Comparative Evaluation of IL-2, IL-15, and IL-211

Qingsheng Li, C. Clegg, P. Shrikant, 2004, The Journal of Immunology.

NY‐ESO‐1 protein glycosylated by yeast induces enhanced immune responses

E. Fischer, J. Karbach, V. Cerundolo, 2010, Yeast.

Immunity : Comparative Evaluation of IL-2 , Responses to Achieve Durable Tumor T Cell + IL-21 Enhances and Sustains CD 8

Qingsheng Li, C. Clegg, P. Shrikant, 2004 .

Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation

K. Odunsi, P. Shrikant, R. Edwards, 2012, Cancer Immunology, Immunotherapy.

Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.

Kunle Odunsi, K. Odunsi, B. Hylander, 2006, Gynecologic Oncology.

Epigenetic Regulation of Ovarian Tumor Immunity

P. Shrikant, 2010 .

Tc17 Cells Are Capable of Mediating Immunity to Vaccinia Virus by Acquisition of a Cytotoxic Phenotype

M. Kaplan, Qingsheng Li, P. Shrikant, 2010, The Journal of Immunology.

a Cytotoxic Phenotype of Immunity to Vaccinia Virus by Acquisition Tc17 Cells Are Capable of Mediating

M. Kaplan, Qingsheng Li, P. Shrikant, 2010 .

Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes

M. Ballestas, P. Shrikant, E. Benveniste, 1994, Journal of Neuroimmunology.

Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines.

R. Ransohoff, P. Shrikant, E. Benveniste, 1995, Journal of immunology.

Activation-Induced Nonresponsiveness: A Th-Dependent Regulatory Checkpoint in the CTL Response1

P. Shrikant, M. Mescher, E. L. Tham, 2002, The Journal of Immunology.

Stimulus-specific inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta.

R. Ransohoff, P. Shrikant, I. Kalvakolanu, 1996, Journal of immunology.

Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes.

M. Ballestas, P. Shrikant, E. Benveniste, 1994, Journal of neuroimmunology.

Aspergillus fumigatus extract differentially regulates antigen‐specific CD4+ and CD8+ T cell responses to promote host immunity

Qingsheng Li, P. Shrikant, B. Segal, 2006, Journal of leukocyte biology.

Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

Lloyd J. Old, Kunle Odunsi, Austin Miller, 2010, Proceedings of the National Academy of Sciences.

Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1

K. Odunsi, L. Old, P. Shrikant, 2008, Cancer Immunology and Immunotherapy.

Fine-tuning CD8+ T-cell functional responses: mTOR acts as a rheostat for regulating CD8+ T-cell proliferation, survival and differentiation?

Qingsheng Li, Rajesh R. Rao, P. Shrikant, 2010, Cell cycle.

Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation.

Qingsheng Li, Qingsheng Li, M. G. Gubbels Bupp, 2012, Immunity.

Angiostatic activity of the antitumor cytokine interleukin-21.

W. Leonard, A. Griffioen, J. V. van Beijnum, 2008, Blood.

Characterizing Host Immune Responses by Monitoring Fluorescently Marked Cells

Qingsheng Li, P. Shrikant, C. Eppolito, 2007, Immunological investigations.

CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer

K. Odunsi, P. Shrikant, S. Battaglia, 2020, Journal for ImmunoTherapy of Cancer.

The Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity

Steffen Jung, E. Tartour, W. Fridman, 2006, European journal of immunology.

Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells

P. Shrikant, R. Srivastava, F. Kos, 2016, Cancer Immunology, Immunotherapy.

Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery1

L. Stamatatos, P. Shrikant, D. Kozbor, 2006, The Journal of Immunology.

Th-Dependent Regulatory Checkpoint in the Activation-Induced Nonresponsiveness: A

P. Shrikant, M. Mescher, E. L. Tham, 2002 .

Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines

P. Shrikant, J. Subjeck, Hyung L. Kim, 2011, British Journal of Cancer.

Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6.

T. Jilling, P. Shrikant, E. Benveniste, 1995, Journal of immunology.

β‐Catenin mediates tumor‐induced immunosuppression by inhibiting cross‐priming of CD8+ T cells

I. Mellman, R. Flavell, P. Shrikant, 2014, Journal of leukocyte biology.

CXCR6 enforced retention promotes resident memory CD8 T cell- mediated immunosurveillance and control of ovarian cancer

K. Odunsi, P. Shrikant, S. Battaglia, 2021 .

CXCR6 governs the retention of tissue-resident memory T cells to promote enhanced surveillance and control of ovarian cancer

K. Odunsi, P. Shrikant, S. Battaglia, 2020 .

negatively regulated by LAG-3 and PD-1 in human ovarian cancer

K. Odunsi, L. Old, Austin Miller, 2010 .

Second Messenger Systems in the Regulation of Cytokines and Adhesion Molecules in the Central Nervous System

M. Ballestas, P. Shrikant, E. Benveniste, 1995, Brain, Behavior, and Immunity.

A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity.

Qingsheng Li, K. Odunsi, Kristen N. Pollizzi, 2011, Immunity.